Cui Yi-min

602 total citations
36 papers, 405 citations indexed

About

Cui Yi-min is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Cui Yi-min has authored 36 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Cui Yi-min's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Orthopaedic implants and arthroplasty (3 papers) and Epilepsy research and treatment (3 papers). Cui Yi-min is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Orthopaedic implants and arthroplasty (3 papers) and Epilepsy research and treatment (3 papers). Cui Yi-min collaborates with scholars based in China, United States and Japan. Cui Yi-min's co-authors include Xiaohong Chen, Chao Shen, Koichi Sugimoto, Akio Fujimura, Qian Xiang, Guiquan Cai, Jiulin Du, Junfeng Zhu, Suodi Zhai and Fude Cui and has published in prestigious journals such as Advanced Materials, Cancer and Stroke.

In The Last Decade

Cui Yi-min

32 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cui Yi-min China 12 63 61 49 47 46 36 405
Nahoko Kurosawa Japan 11 46 0.7× 33 0.5× 59 1.2× 67 1.4× 84 1.8× 30 427
Michael Böettcher Germany 10 95 1.5× 115 1.9× 34 0.7× 88 1.9× 47 1.0× 22 499
R. Calvo Spain 14 32 0.5× 65 1.1× 65 1.3× 83 1.8× 88 1.9× 47 538
G Hitzenberger Austria 9 76 1.2× 74 1.2× 26 0.5× 42 0.9× 29 0.6× 44 322
Anisha E. Mendonza United States 10 22 0.3× 77 1.3× 26 0.5× 73 1.6× 77 1.7× 20 320
James J. Ferry United States 17 39 0.6× 80 1.3× 68 1.4× 93 2.0× 66 1.4× 37 775
M. Guerret France 13 60 1.0× 58 1.0× 35 0.7× 56 1.2× 37 0.8× 26 374
Yoshiro Tomono Japan 8 24 0.4× 123 2.0× 60 1.2× 40 0.9× 50 1.1× 23 426
Christian Mignat Germany 9 15 0.2× 53 0.9× 26 0.5× 95 2.0× 63 1.4× 12 404
Andrew J. Ocque United States 11 55 0.9× 48 0.8× 24 0.5× 277 5.9× 70 1.5× 19 678

Countries citing papers authored by Cui Yi-min

Since Specialization
Citations

This map shows the geographic impact of Cui Yi-min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Yi-min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Yi-min more than expected).

Fields of papers citing papers by Cui Yi-min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cui Yi-min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Yi-min. The network helps show where Cui Yi-min may publish in the future.

Co-authorship network of co-authors of Cui Yi-min

This figure shows the co-authorship network connecting the top 25 collaborators of Cui Yi-min. A scholar is included among the top collaborators of Cui Yi-min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cui Yi-min. Cui Yi-min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Mengyao, Cui Yi-min, & Qian Xiang. (2025). Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. Theranostics. 15(5). 1715–1740. 11 indexed citations
2.
3.
4.
5.
Yan, Mengyao, Zhe Wang, Zhiwei Qiu, Cui Yi-min, & Qian Xiang. (2024). Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy. Biomarker Research. 12(1). 164–164. 10 indexed citations
6.
Zhou, Shuang, Rui Li, Xiaolin Zhang, et al.. (2023). The effects of pharmaceutical interventions on potentially inappropriate medications in older patients: a systematic review and meta-analysis. Frontiers in Public Health. 11. 1154048–1154048. 12 indexed citations
7.
8.
Wushouer, Haishaerjiang, Ziyue Xu, Chaoyang Chen, et al.. (2021). Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study. Frontiers in Pediatrics. 9. 679203–679203. 3 indexed citations
9.
Yi-min, Cui, et al.. (2016). Evaluation of the population pharmacokinetic models of oxcarbazepine in pediatric patients with epilepsy. 25(6). 673. 1 indexed citations
10.
11.
Yi-min, Cui. (2013). Safety of Linagliptin for Type 2 Diabetes Mellitus: a Systematic Review. 1 indexed citations
12.
Frost, Charles, Cui Yi-min, Yan Song, et al.. (2013). Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects. Clinical Pharmacology Advances and Applications. 5. 177–177. 32 indexed citations
13.
Cai, Guiquan, Junfeng Zhu, Chao Shen, et al.. (2012). The Effects of Cobalt on the Development, Oxidative Stress, and Apoptosis in Zebrafish Embryos. Biological Trace Element Research. 150(1-3). 200–207. 40 indexed citations
14.
Chen, Xiaohong, Cui Yi-min, & Chao Shen. (2010). Treatment of developmental dysplasia of the hip with periacetabular osteotomy.. Zhonghua guke zazhi. 30(2). 143–147. 1 indexed citations
15.
Yi-min, Cui. (2008). Tolerability and pharmacokinetics of tratinterol hydrochloride tablets in healthy subjects after a single dose administration. The Chinese Journal of Clinical Pharmacology. 3 indexed citations
16.
Sugimoto, Koichi, Masami Ohmori, Kenichi Harada, et al.. (2006). Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam. European Journal of Clinical Pharmacology. 62(3). 209–215. 21 indexed citations
17.
Wu, Kehua, et al.. (2005). POPULATION PHARMACOKINETICS OF CYCLOSPORINE IN CLINICAL RENAL TRANSPLANT PATIENTS. Drug Metabolism and Disposition. 33(9). 1268–1275. 41 indexed citations
18.
Yi-min, Cui, et al.. (2004). Chronotoxicity of Nedaplatin in Rats. Chronobiology International. 21(4-5). 601–611. 13 indexed citations
19.
Yi-min, Cui, et al.. (2003). Mifepristone‐induced abortion and birth weight in the first subsequent pregnancy. International Journal of Gynecology & Obstetrics. 84(3). 229–235. 5 indexed citations
20.
Yi-min, Cui, et al.. (2003). Evaluation of Chronopharmacodynamics of Indomethacin by the Kaolin-Induced Pain Model in Mice. Chronobiology International. 20(3). 473–484. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nahoko Kurosawa Breakdown of academic impact, for papers by Michael Böettcher Breakdown of academic impact, for papers by R. Calvo Breakdown of academic impact, for papers by G Hitzenberger Breakdown of academic impact, for papers by Anisha E. Mendonza Breakdown of academic impact, for papers by James J. Ferry Breakdown of academic impact, for papers by M. Guerret Breakdown of academic impact, for papers by Yoshiro Tomono Breakdown of academic impact, for papers by Christian Mignat Breakdown of academic impact, for papers by Andrew J. Ocque
Rankless by CCL
2026